{
    "code": "02024701",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024701",
    "time": "2022-10-28 05:07:32",
    "許可證字號": "衛署藥輸字第024701號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/09\/26",
    "發證日期": "96\/09\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202470103",
    "中文品名": "歐思廷凍晶注射劑",
    "英文品名": "Oxitan Lyophilized Powder for Injection",
    "適應症": "和5-fluorouracil (5-FU)和folinic acid (FA)併用，作為─ 第三期結腸癌 (Duke' sC)原發腫瘤完全切除手術後的輔助療法。─ 治療轉移性結腸直腸癌。",
    "劑型": "243凍晶注射劑",
    "包裝": "50mg,100mg小瓶 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OXALIPLATIN",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
    "申請商地址": "台北市大安區仁愛路三段30號5樓32號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0164000  FRESENIUS KABI ONCOLOGY LIMITED",
            "製造廠廠址": "19, HPSIDC, INDUSTRIAL AREA, BADDI, DISTT. SOLAN, HIMACHAL PRADESH 173205, INDIA.",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012001600",
            "成分名稱": "OXALIPLATIN",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1012001600",
            "成分名稱": "OXALIPLATIN",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020247010008.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024701&Seq=008&Type=9"
        },
        {
            "title": "020247010005.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024701&Seq=005&Type=8"
        }
    ]
}